Stock HOWL WEREWOLF THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Werewolf Therapeutics, Inc.

Equities

HOWL

US95075A1079

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-28 pm EDT 		5-day change 1st Jan Change
4.96 USD +1.64% Intraday chart for Werewolf Therapeutics, Inc. -0.80% +28.50%
May. 23 Werewolf Therapeutics to Present Updated Data from Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors at 2024 ASCO Annual Meeting CI
May. 03 Werewolf Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

  1. Stock Market
  2. Equities
  3. HOWL Stock
  4. Revisions Werewolf Therapeutics, Inc.